Acute Phase IL-10 Plasma Concentration Associates with the High Risk Sources of Cardiogenic Stroke
Open Access
- 29 April 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (4) , e0120910
Abstract
Etiological assessment of stroke is essential for accurate treatment decisions and for secondary prevention of recurrence. There is evidence that interleukin-10 (IL-10) associates with ischemic stroke. The aim of this prospective study was to assess the levels of IL-10 in ischemic stroke with unknown or suspected cardiogenic etiology, and evaluate the correlation between IL-10 plasma concentration and the number of diagnosed high risk sources for cardioembolism. A total of 141 patients (97 males; mean age 61±11 years) with acute ischemic stroke with unknown etiology or suspected cardiogenic etiology other than known atrial fibrillation (AF) underwent imaging investigations to assess high risk sources for cardioembolic stroke established by the European Association of Echocardiography (EAE). IL-10 was measured on admission to the hospital and on a three month follow-up visit. Acute phase IL-10 concentration was higher in patients with EAE high risk sources, and correlated with their number (p<0.01). In patients with no risk sources (n = 104), the mean IL-10 concentration was 2.7±3.1 ng/L (range 0.3–16.3 ng/L), with one risk source (n = 26) 3.7±5.5 ng/L (0.3–23.6 ng/L), with two risk sources (n = 10) 7.0±10.0 ng/L (1.29–34.8 ng/L) and with three risk sources (n = 1) 37.2 ng/L. IL-10 level was not significantly associated with cerebral infarct volume, presence of previous or recent myocardial infarction, carotid/vertebral artery atherosclerosis, paroxysmal AF registered on 24-hour ECG Holter monitoring or given intravenous thrombolytic treatment. IL-10 plasma concentration correlates independently with the number of EAE cardioembolic risk sources in patients with acute stroke. IL-10 may have potential to improve differential diagnostics of stroke with unknown etiology.Keywords
This publication has 40 references indexed in Scilit:
- Left Atrial Appendage Volume Increased in More Than Half of Patients with Cryptogenic StrokePLOS ONE, 2013
- Relationship of Serum Interleukin-10 and Its Genetic Variations with Ischemic Stroke in a Chinese General PopulationPLOS ONE, 2013
- Early Biomarkers of Clinical–Diffusion Mismatch in Acute Ischemic StrokeStroke, 2011
- Inflammatory mechanisms in ischemic stroke: therapeutic approachesJournal of Translational Medicine, 2009
- Inflammation and StrokeStroke, 2002
- lnterleukin-10 in the BrainCritical Reviews in Immunology, 2001
- Subtypes of Ischemic StrokeStroke, 1997
- DOWN‐REGULATION OF FIBRINOGEN BIOSYNTHESIS BY IL‐4, IL‐10 AND IL‐13British Journal of Haematology, 1996
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Right Ventricular Volume Determinations in ChildrenCirculation, 1973